Literature DB >> 15081905

Characterizing high-affinity antigen/antibody complexes by kinetic- and equilibrium-based methods.

Andrew W Drake1, David G Myszka, Scott L Klakamp.   

Abstract

Two biophysical methods, Biacore and KinExA, were used to kinetically and thermodynamically characterize high-affinity antigen/antibody complexes. Three to five independent experiments were performed on each platform with three different antigen/antibody complexes possessing nanomolar to picomolar equilibrium dissociation constants. By monitoring the dissociation phase on Biacore for 4 h, we were able to measure dissociation rate constants (kd) on the order of 1 x 10(-5)s(-1). To characterize high-affinity interactions by KinExA, samples needed to be equilibrated for up to 35 h to reach equilibrium. In the end, we show that similar kinetic rate constants and affinities were determined with both solution-phase and solid-phase methodologies. These results help further validate both interaction technologies and illustrate their suitability for characterizing extremely high-affinity interactions.

Mesh:

Substances:

Year:  2004        PMID: 15081905     DOI: 10.1016/j.ab.2003.12.025

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  26 in total

1.  TonB induces conformational changes in surface-exposed loops of FhuA, outer membrane receptor of Escherichia coli.

Authors:  Karron J James; Mark A Hancock; Violaine Moreau; Franck Molina; James W Coulton
Journal:  Protein Sci       Date:  2008-07-24       Impact factor: 6.725

2.  Multispot, label-free biodetection at a phantom plastic-water interface.

Authors:  Fabio Giavazzi; Matteo Salina; Roberto Cerbino; Mattia Bassi; Davide Prosperi; Erica Ceccarello; Francesco Damin; Laura Sola; Marco Rusnati; Marcella Chiari; Bice Chini; Tommaso Bellini; Marco Buscaglia
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-21       Impact factor: 11.205

3.  Identification of pathogenic bacteria in human blood using IgG-modified Fe3O4 magnetic beads as a sorbent and MALDI-TOF MS for profiling.

Authors:  Jia Yi; Qin Qin; Yan Wang; Rutan Zhang; Hongyan Bi; Shaoning Yu; Baohong Liu; Liang Qiao
Journal:  Mikrochim Acta       Date:  2018-11-10       Impact factor: 5.833

4.  Cell-Binding Assays for Determining the Affinity of Protein-Protein Interactions: Technologies and Considerations.

Authors:  S A Hunter; J R Cochran
Journal:  Methods Enzymol       Date:  2016-08-08       Impact factor: 1.600

5.  Impact of SPR biosensor assay configuration on antibody: Neonatal Fc receptor binding data.

Authors:  Xiangdan Wang; Patrick McKay; Liliana T Yee; George Dutina; Philip E Hass; Ihsan Nijem; David Allison; Kyra J Cowan; Kevin Lin; Valerie Quarmby; Jihong Yang
Journal:  MAbs       Date:  2016-12-21       Impact factor: 5.857

6.  PRL3-zumab, a first-in-class humanized antibody for cancer therapy.

Authors:  Min Thura; Abdul Qader Omer Al-Aidaroos; Wei Peng Yong; Koji Kono; Abhishek Gupta; You Bin Lin; Kousaku Mimura; Jean Paul Thiery; Boon Cher Goh; Patrick Tan; Ross Soo; Cheng William Hong; Lingzhi Wang; Suling Joyce Lin; Elya Chen; Sun Young Rha; Hyun Cheol Chung; Jie Li; Sayantani Nandi; Hiu Fung Yuen; Shu-Dong Zhang; Yeoh Khay Guan; Jimmy So; Qi Zeng
Journal:  JCI Insight       Date:  2016-06-16

7.  Production and characterisation of a neutralising chimeric antibody against botulinum neurotoxin A.

Authors:  Julie Prigent; Christelle Mazuet; Didier Boquet; Patricia Lamourette; Hervé Volland; Michel R Popoff; Christophe Créminon; Stéphanie Simon
Journal:  PLoS One       Date:  2010-10-08       Impact factor: 3.240

Review 8.  Label-free cytokine micro- and nano-biosensing towards personalized medicine of systemic inflammatory disorders.

Authors:  Pengyu Chen; Nien-Tsu Huang; Meng-Ting Chung; Timothy T Cornell; Katsuo Kurabayashi
Journal:  Adv Drug Deliv Rev       Date:  2015-09-25       Impact factor: 15.470

9.  Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors.

Authors:  Yasmina Noubia Abdiche; Dan Stephen Malashock; Jaume Pons
Journal:  Protein Sci       Date:  2008-05-27       Impact factor: 6.725

10.  High molecular weight blood group A trisaccharide-polyacrylamide glycoconjugates as synthetic blood group A antigens for anti-A antibody removal devices.

Authors:  Azadeh Alikhani; Elena Y Korchagina; Alexander A Chinarev; Nicolai V Bovin; William J Federspiel
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-11       Impact factor: 3.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.